Find clinical trials for Diabetes in Cincinnati, OH
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Diabetes trials near Cincinnati, OH, USA:
The primary objective of Part 1 of this study is to evaluate safety and tolerability of single subcutaneous (SC) doses of PATAS in healthy subjects....
Phase 1
Cincinnati, Ohio, United States
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...
Phase 2
Cincinnati, Ohio, United States and 40 other locations
Acellular and Matrix-Like Products) and Standard of Care work when compared to Standard of Care alone in achieving complete closure of diabetic...
Phase 4
Cincinnati, Ohio, United States and 3 other locations
Multi-Center, Prospective, Randomized, Controlled Study to Evaluate the Safety and Efficacy of Topically Applied PEP-TISSEEL in Subjects with Diabetic...
Phase 2
Blue Ash, Ohio, United States
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.
Phase 3
Cincinnati, Ohio, United States and 186 other locations
it takes the body to remove it in pediatric participants with Type 2 Diabetes Mellitus (T2DM). The study will last for approximately 100 day...
Phase 1
Cincinnati, Ohio, United States and 9 other locations
double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...
Phase 2
Cincinnati, Ohio, United States and 96 other locations
This is a randomized, masked, active-controlled, parallel-group, multi-center study that will assess the efficacy of ILUVIEN as a baseline therapy in...
Phase 4
Cincinnati, Ohio, United States and 39 other locations
study is to investigate efficacy and safety of three doses of petrelintide versus placebo in participants with overweight or obesity and type 2 diabetes...
Phase 2
Cincinnati, Ohio, United States and 48 other locations
of LY3841136 for chronic weight management alone or in combination with Tirzepatide across a wide dose range in participants with Type 2 Diabetes...
Phase 2
Cincinnati, Ohio, United States of America and 51 other locations
Clinical trials
Research sites
Resources
Legal